Abstract
Background: The metastatic status of the axillary nodes is prognostically important but its value has been questioned in the management of nonpalpable breast tumors. This study correlates the incidence of positive nodes with the size of the primary nonpalpable tumors.
Methods: We retrospectively analyzed 220 invasive and 21 microinvasive breast cancers that were excised after needle localization and for which axillary dissections were subsequently performed. Of invasive cancers, 166 presented as mass lesions with or without microcalcifications and 54 as microcalcifications alone. The size of the mass lesions (n=166) was determined mammographically and on pathologic specimens. They were subdivided into five groups according to diameter: (a) ⩽5 mm, (b) 6–10 mm, (c) 11–20 mm, (d) >20 mm, and (e) unrecorded size.
Results: Axillary metastases were found in 9% of patients whose cancer presented as microcalcifications alone. They were found in 0, 11, and 22% of patients in mammographic groups, a, b, and c, respectively. In the corresponding groups in which size was determined from the pathology report, metastases were found in 5, 10, and 27%.
Conclusion: The size of nonpalpable breast cancers measured on the excised gross specimen and by mammogram accurately predicts the likelihood of axillary node metastasis.
Similar content being viewed by others
References
Tabar L, Fagerberg G, Duff SW, Day NE, Gad A, Grötoft O. Update of the Swedish two county program of mammographic screening for breast cancer.Radiol Clin North Am 1992;30:187–210.
Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1 N0 M0) and stage II (T1 N1 M0) breast carcinoma.J Clin Oncol 1989;7:355–66.
Ciatto S, Cecchini S, Lossa A, Grazzini G, Bravetti P, Rosselli M, Cataliotti L, et al. Prognosis of nonpalpable infiltrating carcinoma of the breast.Surg Gynecol Obstet 1990;170:61–4.
Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gammagami P. Axillary lymph node dissection for T1a breast carcinoma.Cancer 1994;73:664–7.
Cady B. The need to re-examine axillary lymph node dissection in invasive breast cancer.Cancer 1994;73:505–8.
Dowlaishahi K, Yaremko ML, Kluskens LF, Jukich PM. Nonpalpable breast lesions: Findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology.Radiology 1991;181:745–50.
Carter DL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases.Cancer 1989;63:181–7.
Silverstein MJ, Gammagami P, Gierson ED, Semofek GM, Furmanski M, Colburn WJ. Mammographically detected nonpalpable breast carcinoma: superior survival when compared with palpable breast cancer. In:46th Cancer Symposium: Society of Surgical Oncology, Los Angeles, CA, 1993:61.
Alexander HR, Candela FC, Dershaw DD, Kinne DW. Needle-localized mammographic lesions.Arch Surg 1990;125:1441–4.
Perdue P, Page D. Nellestein M, Salmen C, Galbo C, Ghosh B. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions.Surgery 1992;111:656–9.
Schwartz GF, Carter DL, Conant EF, Gannon FH, Finkel GC, Feig SA. Mammographically-detected breast cancer: nonpalpable is not a synonym for inconsequential.Cancer 1994;73:1660–5.
Luini A, Sacchini V, Galimberti V, Ferranti C, Cosmacini P, Farante G, Veronesi P, et al. Preoperative localization and surgical approach in 344 cases on non-palpable breast lesions.Eur J Surg Oncol 1991;17:480–4.
McKinney CD, Frierson HF, Fechner RE, Wilhelm MC, Edge SB. Pathologic findings in nonpalpable invasive breast cancer.Am J Surg Pathol 1992;16:33–6.
Symmonds RE, Roberts JW. Management of nonpalpable breast abnormalities.Ann Surg 1987;205:520–8.
Tinnemans JGM, Wobbes T, Holland R, Hendriks JHCL, Van Der Sluis RF, DeBoer HHM. Treatment and survival of female patients with nonpalpable breast carcinoma.Ann Surg 1989;209:249–53.
Santini D, Bassocchi F, Ricci M, Gelli MC, Taffurelli M, Grassigli A, Marrano D. Prognostic consideration of minimal breast cancer.Breast Cancer Res Treat 1986;8:104.
Sacchini V, Coopmans de Yoldi GF, Rilke F, Luini A, Greco M, Veronesi V. Nonpalpable breast lesions: analysis of 561 operated cases.46th Annual Cancer Symposium: Society of Surgical Oncology, Los Angeles, CA, 1993:169.
Solin LJ, Foble BL, Yeh I-T, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation.Int J Radiat Oncol Biol Phys 1992;23:961–8.
Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.Arch Surg 1990;125:1298–302.
Radford DM, Cromack DT, Troop BR, Keller SM, Lopez MJ. Pathology and treatment of impalpable breast lesions.Am J Surg 1992;164:427–43.
Bettelheim R, Price KN, Gelber RD, Davis BW, Castiglione M, Goldhirsch A, Neville AM. Prognostic importance of occult axillary lymph node micrometastases from breast cancers.Lancet 1990;335:1565–8.
Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in “node-negative” breast carcinoma.Hum Pathol 1993;24:950–7.
Hainsworth PJ, Tjandra JJ, Stillwell RJ, Machet D, Henderson MA, Rennie GC, McKenzie IFC, et al. Detection and significance of occult metastases in node-negative breast cancer.Br J Surg 1993;80:459–63.
Wilkinson EJ, Hanse LL, Hoffman RG, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases.Pathol Annu 1982;17:67–91.
Chadha M, Chabon MB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer.Cancer 1994;73:350–3.
Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer.Ann Surg 1993;218:338–49.
Balch CM, Singletary SE, Bland KI. Clinical decision making in early breast cancer.Ann Surg 1993;217:207–25.
Rosen PP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term followup.J Clin Oncol 1993;11:2090–100.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dowlatshahi, K., Snider, H.C. & Kim, R. Axillary node status in nonpalpable breast cancer. Annals of Surgical Oncology 2, 424–428 (1995). https://doi.org/10.1007/BF02306375
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02306375